IQVIA
Can the UK become a global life sciences superpower?
The latest report from Public Policy Projects and IQVIA highlights a unique opportunity to propel UK life sciences and pharma…
UK’s positive response to Covid-19 can propel the life sciences industry
Opportunity, optimism and challenge – all key themes highlighted in IQVIA’s Annual Life Sciences Innovation Summit, where some of the…
Data Saves Lives – Can Data Catalyse NHS Cancer Recovery?
Will the promise of data to enhance patient outcomes and help the NHS through Covid-19 recovery come true? Disruption to…
Data Saves Lives – Can Data Catalyse NHS Cancer Recovery?
Will the promise of data to enhance patient outcomes and help the NHS through Covid-19 recovery come true? Disruption to…
Covid-19: The catalyst for UK clinical research?
Covid-19 is changing the landscape of UK clinical research, but will these reforms last beyond the pandemic? The holy grail…
IQVIA, ONS, Oxford University and UK Biocentre Launch Accelerated Covid-19 Infection Survey
IQVIA, one of the UK’s leading providers of clinical research, has joined forces with the Office for National Statistics (ONS), Oxford University and UK Biocentre,…
How the global pharmaceutical and biotech sector is responding to COVID-19
Hospital Times Editor David Duffy tuned into an IQVIA webinar, hosted by Pharmaphorum, to ascertain just how the global pharma and biotech sectors…
Harnessing UK innovation for the rare disease community
How does government, NHS and industry balance competing priorities to ensure that rare disease patients are not left behind in…